✦ LIBER ✦

Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study

✍ Scribed by Masataka Sawaki, Hirofumi Mukai, Nahomi Tokudome, Takahiro Nakayama, Naruto Taira, Toshiro Mizuno, Yutaka Yamamoto, Akiyo Horio, Toru Watanabe, Yukari Uemura, Yasuo Ohashi

Book ID: 113101126
Publisher: Springer Japan
Year: 2011
Tongue: English
Weight: 229 KB
Volume: 19
Category: Article
ISSN: 1340-6868
DOI: 10.1007/s12282-011-0270-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination docetaxel and trastuzumab tr

Combination docetaxel and trastuzumab treatment for patients with her-2-overexpressing metastatic breast cancer: A multicenter, phase-II study

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

Characteristics of patients with brain m

Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer

✍ H.J. Stemmler; S. Kahlert; W. Siekiera; M. Untch; B. Heinrich; V. Heinemann 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Adjuvant trastuzumab in elderly with HER

Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials

✍ Janaina Brollo; Giuseppe Curigliano; Davide Disalvatore; Bianca Fontana Marrone; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 293 KB

TEACH phase III study of lapatinib after

TEACH phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-overexpressing breast cancer

✍ B. Mov; J.D. Maltzman; E. Rappold; D. Finkelstein; L.S. Williams; R.E. Goss 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Weekly docetaxel and trastuzumab for her

Weekly docetaxel and trastuzumab for her-2-overexpressing metastatic breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study

✍ S Takao; N Kohno; M Miyashita; I Kokufu; K Wakita 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Cyclin E amplification/overexpression is

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients

✍ Mittendorf, E.A.; Keyomarsi, K.; Hunt, K.K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB